Microalgae have been explored for their bioactive compounds with promising applications encompassing antibacterial, antiviral, antifungal and antialgal activities. Considering the present status of widely used treatment therapies and their limitations to tackle their adverse effects, the application of bioactive compounds derived from algae will prove beneficial and much more effective as compared with traditional treatment methods. Due to the emerging infectious diseases, viral infections (epidemic and pandemic) and raise in antibiotic resistant bacteria, there is an urgent need for development of alternative treatment therapies against infectious diseases. Present work provides a brief introduction about the algal bioactive compounds and their activities against various pathogens.
Open access to the scientific literature means the removal of barriers (including price barriers) from accessing scholarly work. There are two parallel roads towards open access: Open Access articles and self-archiving. Open Access articles are immediately, freely available on their Web site, a model mostly funded by charges paid by the author (usually through a research grant). The alternative for a researcher is self-archiving (i.e., to publish in a traditional journal, where only subscribers have immediate access, but to make the article available on their personal and/or institutional Web sites (including so-called repositories or archives)), which is a practice allowed by many scholarly journals.
Open Access raises practical and policy questions for scholars, publishers, funders, and policymakers alike, including what the return on investment is when paying an article processing fee to publish in an Open Access articles, or whether investments into institutional repositories should be made and whether self-archiving should be made mandatory, as contemplated by some funders.
Last date updated on July, 2014